Is there a relationship between serum ox-LDL, oxidative stress, and PON1 in knee osteoarthritis?

Clinical Rheumatology

Volumn 36, Issue 12, 2017, Pages 2775-2780

  Ertürk, Cemil ^a   Altay, Mehmet Akif ^b   Bilge, Ali ^c   Çelik, Hakim ^b  

^a UNIVERSITY OF HEALTH SCIENCES   (Turkey)

^b HARRAN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c KAFKAS UNIVERSITY   (Turkey)

Author keywords

Ox LDL; Oxidative stress; PON1; Severity of knee OA

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; BIOLOGICAL MARKER; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZING AGENT; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL; LOW DENSITY LIPOPROTEIN; PON1 PROTEIN, HUMAN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CLINICAL EVALUATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; KELLGREN LAWRENCE SCORE; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOLOGICAL PARAMETERS; SCORING SYSTEM; SERUM; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX; BLOOD; DIAGNOSTIC IMAGING; DISEASE EXACERBATION; KNEE; METABOLISM; PHYSIOLOGY; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX;

AGED; ARYLDIALKYLPHOSPHATASE; BIOMARKERS; CHOLESTEROL; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; KNEE JOINT; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; OXIDATIVE STRESS; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX; TRIGLYCERIDES;

EID: 85021051277     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-017-3732-4     Document Type: Article

References (41)

1. Tiku ML, Shah R, Allison GT (2000) Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein degradation. Possible role in cartilage aging and the pathogenesis of osteoarthritis. J Biol Chem 275(26):20069–20076
2. Kishimoto H, Akagi M, Zushi S et al (2010) Induction of hypertrophic chondrocyte-like phenotypes by oxidized LDL in cultured bovine articular chondrocytes through increase in oxidative stress. Osteoarthr Cartil 18(10):1284–1290
3. de Munter W, Blom AB, Helsen MM et a (2013). Cholesterol accumulation caused by low density lipoprotein receptor deficiency or a cholesterol-rich diet results in ectopic bone formation during experimental osteoarthritis. Arthritis Res Ther 15(6):R178. doi: 10.1186/ar4367.
4. Nishimura S, Akagi M, Yoshida K et al (2004) Oxidized low-density lipoprotein (ox-LDL) binding to lectin-like ox-LDL receptor-1 (LOX-1) in cultured bovine articular chondrocytes increases production of intracellular reactive oxygen species (ROS) resulting in the activation of NF-kappaB. Osteoarthr Cartil 12(7):568–576
5. Mazière C, Mazière JC (2009) Activation of transcription factors and gene expression by oxidized low-density lipoprotein. Free Radic Biol Med 46(2):127–137
6. Matsuura E, Hughes GR, Khamashta MA (2008) Oxidation of LDL and its clinical implication. Autoimmun Rev 7(7):558–566
7. Trpkovic A, Resanovic I, Stanimirovic J et al (2015) Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases. Crit Rev Clin Lab Sci 52(2):70–85
8. Levitan I, Volkov S, Subbaiah PV (2010) Oxidized LDL: diversity, patterns of recognition, and pathophysiology. Antioxid Redox Signal 13(1):39–75
9. Gkretsi V, Simopoulou T, Tsezou A (2011) Lipid metabolism and osteoarthritis: lessons from atherosclerosis. Prog Lipid Res 50:133–140
10. Lepetsos P, Papavassiliou AG (2016) ROS/oxidative stress signaling in osteoarthritis. Biochim Biophys Acta 4:576–591
11. Ertürk C, Altay MA, Selek S et al (2012) Paraoxonase-1 activity and oxidative status in patients with knee osteoarthritis and their relationship with radiological and clinical parameters. Scand J Clin Lab Invest 72:433–439
12. Aviram M, Rosenblat M (2004) Paraoxonases 1, 2, and 3,oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Rad Bio Med 37(9): 1304–1316.
13. Loued S, Isabelle M, Berrougui H et al (2012) The anti-inflammatory effect of paraoxonase 1 against oxidized lipids depends on its association with high density lipoproteins. Life Sci 90(1–2):82–88
14. García-Heredia A, Marsillach J, Rull A et al (2013) Paraoxonase-1 inhibits oxidized low-density lipoprotein-induced metabolic alterations and apoptosis in endothelial cells: a nondirected metabolomic study. Mediators Inflamm:156053.
15. Aviram M, Rosenblat M, Billecke S et al (1999) Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med 26(7–8):892–904
16. Aviram M, Kaplan M, Rosenblat M (2005) Dietary antioxidants and paraoxonases against LDL oxidation and atherosclerosis development. Handb Exp Pharmacol 170:263–300
17. Altman R, Asch E, Bloch D et al (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and therapeutic criteria Committee of the American Rheumatism Association. Arthritis Rheum 29:1039–1049
18. Ertürk C, Altay MA, Altay N (2016) Will a single periarticular lidocaine-corticosteroid injection improve the clinical efficacy of intraarticular hyaluronic acid treatment of symptomatic knee osteoarthritis? Knee Surg Sports Traumatol Arthrosc 24(11):3653–3660
19. Kellgren JH, Lawrence JS (1957) Radiological assessment of osteoarthrosis. Ann Rheum Dis 16:494–502
20. Bellamy N, Buchanan WW, Goldsmith CH et al (1957) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840
21. Kurban S, Mehmetoglu I (2010) Effects of acetylsalicylic acid on serum paraoxonase activity, ox-LDL, coenzyme Q10 and other oxidative stress markers in healthy volunteers. Clin Biochem 43(3):287–290
22. Altay MA, Ertürk C, Bilge A et al (2015) Evaluation of prolidase activity and oxidative status in patients with knee osteoarthritis: relationships with radiographic severity and clinical parameters. Rheumatol Int 35(10):1725–1731
23. Altay MA, Ertürk C, Levent A (2016) Çetin BV, Aksoy N. Serum prolidase activity and oxidative-antioxidative status in patients with developmental dysplasia of the hip and its relationship with radiographic severity. Redox Rep 20:1–8. doi:10.1080/13510002.2016.1196873
24. Meisinger C, Baumert J, Khuseyinova N et al (2005) Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation 112(5):651–657
25. Roy Chowdhury SK, Sangle GV, Xie X (2010) Effects of extensively oxidized low-density lipoprotein on mitochondrial function and reactive oxygen species in porcine aortic endothelial cells. Am J Physiol Endocrinol Metab 298(1):E89–E98
26. Mitra S, Goyal T, Mehta JL (2011) Oxidized LDL, LOX-1 and atherosclerosis. Cardiovasc Drugs Ther 25(5):419–429
27. Hong D, Bai YP, Gao HC et al (2014) Ox-LDL induces endothelial cell apoptosis via the LOX-1-dependent endoplasmic reticulum stress pathway. Atherosclerosis 2:310–317
28. Villalvilla A, Gómez R, Largo R et al (2013) Lipid transport and metabolism in healthy and osteoarthritic cartilage. Int J Mol Sci 14(10):20793–20808
29. Berenbaum F (2013) Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthr Cartil 21(1):16–21
30. Mehta JL, Chen J, Hermonat PL et al (2006) Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovasc Res 69(1):36–45
31. Simopoulou T, Malizos KN, Tsezou A (2007) Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) expression in human articular chondrocytes. Clin Exp Rheumatol 25(4):605–612
32. Cillero-Pastor B, Eijkel G, Kiss A et al (2012) Time-of-flight secondary ion mass spectrometry-based molecular distribution distinguishing healthy and osteoarthritic human cartilage. Anal Chem 84(21):8909–8916
33. Kosinska MK, Liebisch G, Lochnit G et al (2013) A lipidomic study of phospholipid classes and species in human synovial fluid. Arthritis Rheum 65(9):2323–2333
34. Girotti AW (1998) Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res 39:1529–1542
35. de Farias CC, Maes M, Bonifácio KL et al (2016) Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson's disease and its progression: disease and staging biomarkers and new drug targets. Neurosci Lett 617:66–71
36. Mackness MI, Mackness B, Durrington PN (1996) Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 7(2):69–76
37. Akagi M, Kanata S, Mori S et al (2007) Possible involvement of the oxidized low-density lipoprotein/lectin-like oxidized low-density lipoprotein receptor-1 system in pathogenesis and progression of human osteoarthritis. Osteoarthr Cartil 15(3):281–290
38. Ishijima M, Watari T, Naito K et al (2011) Relationships between biomarkers of cartilage, bone, synovial metabolism and knee pain provide insights into the origins of pain in early knee osteoarthritis. Arthritis Res Ther 13:R22
39. Henrotin Y, Lambert C, Couchourel D et al (2011) Nutraceuticals: do they represent a new era in the management of osteoarthritis? - a narrative review from the lessons taken with five products. Osteoarthr Cartil 19(1):1–21
40. Ertürk C, Altay MA, Sert C et al (2015) The body composition of patients with knee osteoarthritis: relationship with clinical parameters and radiographic severity. Aging Clin Exp Res 27(5):673–679
41. Kadam UT, Blagojevic M, Belcher J (2013) Statin use and clinical osteoarthritis in the general population: a longitudinal study. J Gen Intern Med 28(7):943–949